Physician profile
Grigoriy Efros
NPI 1265828297
$2,492.67
in general payments reported to CMS, 2019-2025
8 companies · $549 in 2025
The $549 reported for 2025 was more than what 91% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $363 · 2021: $411 · 2022: $210 · 2023: $87.84 · 2024: $655 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117 · Gift: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.04 |
| Gift | $174.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Orthodontics Corporation | $1,092.23 | 2020-2025 | Radiance, Empower-Ceramic, Empower-Metal |
| Align Technology, INC. | $1,060.01 | 2019-2025 | Invisalign, Itero Element 5d Plus Lite |
| Lightforce Orthodontics, INC. | $145.26 | 2022 | |
| Biohorizons Implant Systems INC. | $87.17 | 2021-2022 | |
| Envista Holdings Corporation | $48.71 | 2024-2025 | Miniendo II, Spark |
| Philips North America LLC | $34.60 | 2024-2025 | Oral Health Care Undivided, (E55) Oral Health Care Und |
| Dentsply Sirona INC | $13.90 | 2020 | |
| 3m Company | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grigoriy Efros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.